The sensitivity of axillary staging when using sentinel node biopsy in breast cancer

European Journal of Surgical Oncology

Volumn 29, Issue 10, 2003, Pages 849-853

  Leidenius, Marjut ^a   Krogerus, L ^b   Toivonen, T ^b   Leppanen E ^b   Von Smitten, K ^a  

^a Maria Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Axillary metastases; Breast cancer; Sentinel node biopsy

Indexed keywords

RADIOISOTOPE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOACTIVITY; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

EID: 0345170042     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.09.014     Document Type: Article

References (25)

1. Giuliano AE, Dale PS, Turner RR et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
2. Roumen RMH, Kuijt GP, Liem IH, van Beek MWPM. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001; 88: 1639-43.
3. Morton DL, Wen D, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
4. McMasters KM, Tutle TM, Carlson DJ et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18: 2560-6.
5. Borgstein PJ, Pijpers R, Comans EF et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
6. O'Hea BJ, Hill ADK, El-Shirbiny AM et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
7. Valdés Olmos RA, Tanis PJ, Hoefnagel CA et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22: 579-86.
8. Lee A, Keshtgar M, Waddington W, Ell P. The role of dynamic imaging in sentinel lymph node biopsy in breast cancer. Eur J Cancer 2002; 38: 784-7.
9. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84: 138-42.
10. Fentiman IS, Mansel RE. The sentinel node negative axilla; is it a no-go zone? Cancer Treat Rev 2002; 28: 1-3.
11. Simmons RM. Review of sentinel lymph node credentialing: how many cases are enough? J Am Coll Surg 2001; 193: 206-9.
12. Nieweg OE, Rutgers EJT, Jansen L et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001; 25: 780-7.
13. Tanis PJ, Nieweg OE, Hart AAM, Kroon BBR. The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol 2002; 9: 142-7.
14. Wong SL, Edwards MJ, Chao C et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false negative rate. J Am Coll Surg 2001; 192: 684-91.
15. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS. The breast cancer with multiple sentinel nodes: when to stop? J Am Coll Surg 2001; 192: 692-7.
16. Martin RCG, Fey J, Yeung H, Borgen PI, Cody HS. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 2001; 8: 592-7.
17. Heuser T, Rink T, Weller ER et al. Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding. Breast Cancer Res Treat 2001; 67: 125-32.
18. Rahusen FD, Pijpers R, van Diest PJ et al. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 2000; 128: 6-12.
19. Tanis PJ, Nieweg OE, Merkus JWS, Peterse JL, Kroon BBR. False negative sentinel node procedure established through palpation of the biopsy wound. Eur J Surg Oncol 2000; 26: 714-21.
20. Schrenk P, Rehberger W, Shamiyeh A, Wayand W. Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on accuracy of finding a positive node? J Surg Oncol 2002; 80: 130-6.
21. Zervos EE, Badgwell BD, Abdessalam SF et al. Selective analysis of the sentinel node in breast cancer. Am J Surg 2001; 182: 372-6.
22. Quan ML, McCready D, Temple WJ, McKinnon JG. Biology of lymphatic metastases in breast cancer: lessons learned from sentinel node biopsy. Ann Surg Oncol 2002; 9: 467-71.
23. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. The effect of lymphatic tumour burden on sentinel lymph node biopsy results. Breast J 2002; 8: 192-8.
24. Rink T, Heuser T, Fitz H et al. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin. Results of an optimized protocol. Clin Nucl Med 2001; 26: 293-8.
25. Leppänen EA, Leldenius MHK, Krogerus LA, von Smitten KJA. The effect of patient and tumour characteristics on visualisation of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol 2002; 28: 821-6.